Taysha Gene Therapies is a biotechnology company based in Dallas, Texas, specializing in the development of gene therapies. Located at 3000 Pegasus Park Drive, Suite 1430, the company focuses on advancing innovative treatments designed to address serious genetic diseases. As a local entity within the biotechnology sector, Taysha Gene Therapies contributes to the growing life sciences community in Dallas by leveraging cutting-edge technology and scientific expertise.
The company’s operations center around research and development, emphasizing precision medicine and gene delivery systems. By working with complex biological mechanisms, Taysha Gene Therapies aims to create solutions that modify genetic material to potentially treat or cure inherited conditions. This focus places the company among a select group of businesses dedicated to transforming therapeutic approaches through biotechnology.
Situated in a city known for its expanding medical and technological industries, Taysha Gene Therapies benefits from proximity to research institutions and healthcare networks. The company maintains communication channels through its Dallas office and can be reached at 214-612-0000 for inquiries. Its role in the local biotechnology landscape underscores a commitment to scientific progress and innovation within the region.
By maintaining a clear dedication to developing novel gene therapies, Taysha Gene Therapies supports advancements that may improve patient outcomes over time. The company’s presence in Dallas reflects a broader trend of biotechnology firms contributing to both regional economic growth and the evolution of medical treatments through genetic science.


































